influenza

The firm plans to release a research-use-only version of its test by the end of the year, and is still hoping for FDA clearance in 2019.

Sensitivity problems with rapid antigen tests are also helping the more accurate rapid molecular tests gain wider acceptance, manufacturers said.

The molecular test can provide results in 30 minutes from nasal swabs on a palm-sized instrument.

Faster Flu Vaccines?

Synthetic Genomics is working on speeding up flu vaccine production, according to the San Diego Union-Tribune.

In Life Sciences, CEO Thomas Joyce noted a strong performance by Beckman Coulter, while in Diagnostics, he said Cepheid grew 25 percent year over year. 

Abbott's CFO said he expects mid-single-digit growth from diagnostics in Q1 2018 and mid-to-high single digit growth for the full year. 

The first available test on the PCR-based Accula platform will be for the diagnosis of influenza A and B virus infection.

The company's microchip-based technology will detect viral and bacterial genetic material using both isothermal amplification and electrochemical measurements.

The new instrument has higher throughput than competing systems, while the flu test boasts enhanced sensitivity and protection against seasonal drift.

The Xpert Xpress Flu can detect both influenza A and B virus in 20 minutes from either nasopharyngeal or nasal swabs.

Pages

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.